A
$ Value
$0
Shares
50,000
Price
$0
Filed
Jan 29
Insider
Name
Adsett Roger
Title
—
CIK
0001685904
Roles
Director
Transaction Details
Transaction Date
2026-01-29
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
50,000
Footnotes
The shares underlying the option shall vest and become exercisable over a three-year period with 1/3 vesting on the first anniversary of the date of the grant and the remaining vesting in 24 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date.
Filing Info
Adsett Roger's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | INSM | M | $1.3M |
| 2026-04-01 | INSM | ▼ | $1.1M |
| 2026-04-01 | INSM | ▼ | $3.1M |
| 2026-04-01 | INSM | ▼ | $10.3M |
| 2026-04-01 | INSM | M | $0 |
| 2026-02-03 | INSM | ▼ | $124K |
| 2026-01-29 | DFTX | A | $0 |
| 2026-01-08 | INSM | ▼ | $359K |
| 2026-01-07 | INSM | ▼ | $140K |
| 2026-01-06 | INSM | ▼ | $248K |
Other Insiders at DFTX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Sullivan Mark
Chief Legal Officer
|
— | $198K | 2026-03-25 |
|
Roberts Brandi
Chief Financial Officer
|
— | — | 2026-02-03 |
|
Wiley Matthew T.
Chief Commercial Officer
|
— | — | 2026-02-03 |
|
Barrow Robert
Chief Executive Officer
|
— | $451K | 2026-03-25 |
|
Karlin Daniel
Chief Medical Officer
|
— | $148K | 2026-03-25 |